Literature DB >> 27456525

Endogenous Ouabain: Recent Advances and Controversies.

John M Hamlyn1, Mordecai P Blaustein1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27456525      PMCID: PMC4982830          DOI: 10.1161/HYPERTENSIONAHA.116.06599

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  94 in total

1.  Liquid chromatography mass spectrometric analysis of ouabainlike factor in biological fluid.

Authors:  Y Komiyama; N Nishimura; X H Dong; S Hirose; C Kosaka; H Masaki; M Masuda; H Takahashi
Journal:  Hypertens Res       Date:  2000-09       Impact factor: 3.872

2.  Ouabain attenuates cardiotoxicity induced by other cardiac steroids.

Authors:  M Nesher; U Shpolansky; N Viola; M Dvela; N Buzaglo; H Cohen Ben-Ami; H Rosen; D Lichtstein
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  The role of excessive volume expansion in the pathogenesis of preeclampsia.

Authors:  Jules B Puschett
Journal:  Med Hypotheses       Date:  2006-07-11       Impact factor: 1.538

4.  Identification and characterization of a ouabain-like compound from human plasma.

Authors:  J M Hamlyn; M P Blaustein; S Bova; D W DuCharme; D W Harris; F Mandel; W R Mathews; J H Ludens
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies.

Authors:  Chiara Lanzani; Lorena Citterio; Nicola Glorioso; Paolo Manunta; Grazia Tripodi; Erika Salvi; Simona Delli Carpini; Mara Ferrandi; Elisabetta Messaggio; Jan A Staessen; Daniele Cusi; Fabio Macciardi; Giuseppe Argiolas; Giovanni Valentini; Patrizia Ferrari; Giuseppe Bianchi
Journal:  Sci Transl Med       Date:  2010-11-24       Impact factor: 17.956

6.  Modulation of the levels of ouabain-like compound by central catecholamine neurons in rats.

Authors:  K Yamada; A Goto; M Omata
Journal:  FEBS Lett       Date:  1995-02-20       Impact factor: 4.124

7.  Effects of dietary sodium on central and peripheral ouabain-like activity in spontaneously hypertensive rats.

Authors:  F H Leenen; E Harmsen; H Yu; C Ou
Journal:  Am J Physiol       Date:  1993-06

8.  Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats.

Authors:  B S Huang; X Huang; E Harmsen; F H Leenen
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

9.  Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.

Authors:  Jan A Staessen; Lutgarde Thijs; Katarzyna Stolarz-Skrzypek; Antonella Bacchieri; John Barton; Ezio Degli Espositi; Peter W de Leeuw; Mirosław Dłużniewski; Nicola Glorioso; Andrzej Januszewicz; Paolo Manunta; Viktor Milyagin; Yuri Nikitin; Miroslav Souček; Chiara Lanzani; Lorena Citterio; Mario Timio; Andrzej Tykarski; Patrizia Ferrari; Giovanni Valentini; Kalina Kawecka-Jaszcz; Giuseppe Bianchi
Journal:  Trials       Date:  2011-01-14       Impact factor: 2.279

10.  EFFECTS OF CHRONIC EXCESS SALT INGESTION. ROLE OF GENETIC FACTORS IN BOTH DOCA-SALT AND RENAL HYPERTENSION.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

Review 2.  How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

Review 3.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

Review 4.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

5.  Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats.

Authors:  Jiao Lu; Hong-Wei Wang; Monir Ahmad; Marzieh Keshtkar-Jahromi; Mordecai P Blaustein; John M Hamlyn; Frans H H Leenen
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

Review 6.  The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-07       Impact factor: 4.249

7.  Reply to "Letter to the editor: Comments on Blaustein (2018): 'The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system'".

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Cell Physiol       Date:  2018-05-01       Impact factor: 4.249

8.  Na+/Ca2+ exchanger overexpression in smooth muscle augments cytosolic Ca2+ in femoral arteries of living mice.

Authors:  Jin Zhang; Youhua Wang; Ling Chen; W Gil Wier; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-21       Impact factor: 4.733

9.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

10.  Sodium sensitivity of KNa channels in mouse CA1 neurons.

Authors:  Richard Gray; Daniel Johnston
Journal:  J Neurophysiol       Date:  2021-03-31       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.